PCNA and GSK3β interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis

X H Liu1, D E Tang2, Y Dai2

  • 1Key Laboratory of Functional Protein Research of Guangdong Higher Education Institute, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China.

Neoplasma
|October 15, 2019
PubMed

Insights

Lithium chloride (LiCl) targets glycogen synthase kinase beta (GSK3β) for lung cancer treatment. This study reveals GSK3β interacts with proliferating cell nuclear antigen (PCNA), influencing apoptosis and LiCl sensitivity.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • Glycogen synthase kinase beta (GSK3β) is a key target for lung cancer therapy, with its inhibitor lithium chloride (LiCl) showing anti-proliferative and apoptosis-modulating effects.
  • Proliferating cell nuclear antigen (PCNA) is crucial for DNA replication and repair, and its role in apoptosis regulation is significant.

Purpose of the Study:

  • To elucidate the interaction between GSK3β and PCNA in lung adenocarcinoma cells.
  • To investigate the regulatory mechanism of GSK3β by PCNA, particularly in response to DNA damage.
  • To determine the functional consequence of the GSK3β-PCNA interaction on lung cancer cell apoptosis and response to LiCl treatment.

Main Methods:

  • GST pull-down and co-immunoprecipitation assays to confirm GSK3β-PCNA interaction in H1299 cells.
  • UVC irradiation to study the dynamic changes in GSK3β-PCNA interaction.
  • Western blotting to assess GSK3β Ser9 phosphorylation levels following PCNA manipulation (overexpression and siRNA knockdown).
  • Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) using LY294002 to probe pathway involvement.
  • Functional assays to evaluate the effect of PCNA downregulation on LiCl-induced apoptosis.

Main Results:

  • GSK3β was found to interact with PCNA in H1299 lung adenocarcinoma cells.
  • The GSK3β-PCNA interaction intensity peaked within 3 hours post-UVC irradiation and subsequently decreased.
  • PCNA overexpression reduced GSK3β Ser9 phosphorylation, while PCNA knockdown increased it, an effect reversed by LY294002, implicating the PI3K-AKT pathway.
  • Downregulation of PCNA enhanced the sensitivity of H1299 cells to LiCl-induced apoptosis.

Conclusions:

  • A novel regulatory interaction between GSK3β and PCNA has been identified in lung adenocarcinoma.
  • The PI3K-AKT pathway plays a role in modulating GSK3β phosphorylation in response to PCNA levels and DNA damage.
  • Targeting the PCNA-GSK3β axis presents a promising therapeutic strategy for lung cancer, potentially enhancing LiCl efficacy.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K